Meilleure Health International Industry Group Limited will convene its board of directors on 27 August 2026 in Hong Kong. The session’s agenda includes:
• Examination and approval of the unaudited interim results for the six months ended 30 June 2026.
• Deliberation on a potential interim dividend for shareholders.
The announcement, dated 13 August 2026, confirms participation from the company’s full board—comprising three executive directors (Mr. Zhou Xuzhou, Dr. Zeng Wentao, Ms. Zhou Wen Chuan), one non-executive director (Dr. Mao Zhenhua) and three independent non-executive directors (Professor Chau Chi Wai, Wilton; Mr. Chen Shi; Mr. Wu Peng).
Executive Director and CEO Ms. Zhou Wen Chuan signed the notice on behalf of the board.